NICHOLS WILLIAM GARRETT (Chief Medical Officer) sold 1.5% of their position (781.00 shares) of CANDEL THERAPEUTICS, INC. on the open market
Open‑market sale worth $3.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/2/2025ACC: 0000950170-25-093035
Officer· Chief Medical Officer
Since Jan 2026
-781.00
Net shares
Net seller
$3.9K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
781.00 acquired · 1.56K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+781.00
Price / share
$1.29
Trade value
$1.01K
% of position
1.5%
6/30/2025
52.49K→53.27K
Common Stock
Direct
Shares
−781.00
Price / share
$5.04
Trade value
$3.94K
% of position
1.5%
6/30/2025
53.27K→52.49K
Total
Net shares
+0.00
Net value
-$2.93K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/30/2025 | M · Option Exercise | +781.00 | $1.29 | $1.01K | 1.5% | 52.49K | 53.27K |
| Common Stock Direct | 6/30/2025 | S · Sale | −781.00 | $5.04 | $3.94K | 1.5% | 53.27K | 52.49K |
| Total | +0.00 | -$2.93K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
781.00 shares
Shares
−781.00
Strike price
1.29
Held after
30.31K
Exercisable
—
6/30/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock781.00 shares | 6/30/2025 | M · Option Exercise | −781.00 | 1.29 | — | 30.31K |